Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

The efficacy of topical agents used in wounds for managing chronic biofilm infections: A systematic review

Publikation: Bidrag til tidsskriftReviewpeer review


  1. Prevalence of biofilms in acute infections challenges a longstanding paradigm

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Nitric-oxide-driven oxygen release in anoxic Pseudomonas aeruginosa

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Dynamics of skin microbiota in shoulder surgery infections

    Publikation: Bidrag til tidsskriftReviewpeer review

  4. Biofilms can act as plasmid reserves in the absence of plasmid specific selection

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  5. The impact of mental models on the treatment and research of chronic infections due to biofilms

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  • S Schwarzer
  • G A James
  • D Goeres
  • T Bjarnsholt
  • K Vickery
  • S L Percival
  • P Stoodley
  • G Schultz
  • S O Jensen
  • M Malone
Vis graf over relationer

OBJECTIVES: Clinicians have increasingly adopted the widespread use of topical agents to manage chronic wound infections, despite limited data on their effectiveness in vivo. This study sought to evaluate the evidence for commonly employed topical agents used in wounds for the purpose of treating chronic infections caused by biofilm.

METHOD: We included in vitro, animal and human in vivo studies where topical agents were tested for their efficacy against biofilms, for use in wound care. For human studies, we only included those which utilised appropriate identification techniques for visualising and confirming the presence of biofilms.

RESULT: A total of 640 articles were identified, with 43 included after meeting eligibility. In vitro testing accounted for 90% (n = 39) of all included studies, five studies using animal models and three human in vivo studies. Sixteen different laboratory models were utilised, with the most frequent being the minimum biofilm eradication concentration (MBEC™) / well plate assay (38%, n = 15 of 39). A total of 44 commercially available topical agents were grouped into twelve categories with the most commonly tested agents being silver, iodine and polyhexamethylene biguanide (PHMB). In vitro results on efficacy demonstrated iodine as having the highest mean log10 reductions of all agents (4.81, ±3.14).

CONCLUSION: There is large disparity in the translation of laboratory studies to researchers undertaking human trials relating to the effectiveness of commercially available topical agents. There is insufficient human in vivo evidence to definitively recommend any commercially available topical agent over another for the treatment of chronic wound biofilms. The heterogeneity identified between study designs (in vitro to in vivo) further limits the generalisability of results.

TidsskriftJournal of Infection
Udgave nummer3
Sider (fra-til)261-270
Antal sider10
StatusUdgivet - mar. 2020

Bibliografisk note

Funding Information:
MM, PS, GS, TB, GJ received a consultancy fee from S&N to undertake work not associated with this study but pertaining to producing educational material on biofilms in chronic wounds. MM received a research grant from Smith and Nephew and Mundi Pharmaceuticals for studies included in this review. All other authors have nothing to declare

ID: 59012082